GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Enzymatica AB (publ) ENZY.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

2.40

-2.04%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 53.9m

FY2016FY2025

Net income

−SEK 51.9m

FY2016FY2025

Free cash flow

−SEK 41.2m

FY2016FY2025

Shareholders' equity

SEK 124.2m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 53.9mSEK 45.6mSEK 50.9mSEK 48.9mSEK 57.2mSEK 111.2mSEK 61.3mSEK 52.6mSEK 59.4mSEK 36.5m
Gross profitSEK 33.1mSEK 30.7mSEK 31.9mSEK 28.5mSEK 33.4mSEK 76.0mSEK 44.9mSEK 36.8mSEK 36.3mSEK 22.2m
Research and developmentSEK 15.7mSEK 15.5mSEK 15.2mSEK 26.5mSEK 24.2mSEK 22.5mSEK 28.5mSEK 20.8mSEK 14.4mSEK 12.3m
Operating income−SEK 52.2m−SEK 52.1m−SEK 47.6m−SEK 67.8m−SEK 44.8m−SEK 12.3m−SEK 41.7m−SEK 40.6m−SEK 30.3m−SEK 46.2m
Net income−SEK 51.9m−SEK 53.2m−SEK 49.7m−SEK 68.7m−SEK 45.4m−SEK 13.2m−SEK 41.0m−SEK 42.6m−SEK 31.4m−SEK 45.0m
Diluted earnings per share-0.21-0.22-0.30-0.42-0.31-0.09-0.29-0.45-0.35-0.50

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 142.0mSEK 195.2mSEK 125.9mSEK 174.4mSEK 157.0mSEK 162.0mSEK 147.7mSEK 185.2mSEK 133.8mSEK 162.6m
Cash and short-term investmentsSEK 33.1mSEK 75.2mSEK 8.4mSEK 50.7mSEK 31.6mSEK 24.0mSEK 29.3mSEK 70.3mSEK 10.9mSEK 35.6m
Total liabilitiesSEK 17.8mSEK 18.9mSEK 49.3mSEK 48.1mSEK 32.1mSEK 55.4mSEK 28.5mSEK 25.5mSEK 23.1mSEK 20.6m
DebtSEK 1.0mSEK 2.2mSEK 18.1mSEK 22.3mSEK 3.9mSEK 15.8mSEK 6.7mSEK 4.8mSEK 2.4mSEK 7.4m
Shareholders' equitySEK 124.2mSEK 176.4mSEK 76.6mSEK 126.3mSEK 125.0mSEK 106.6mSEK 119.2mSEK 159.7mSEK 110.3mSEK 141.7m
Shares outstanding243m243m164m164m147m143m143m95m91m91m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 41.0m−SEK 60.5m−SEK 40.3m−SEK 64.6m−SEK 35.9m−SEK 10.7m−SEK 37.6m−SEK 28.8m−SEK 22.5m−SEK 38.4m
Capital spending−SEK 231,000−SEK 393,000−SEK 730,000−SEK 3.7m−SEK 6.1m−SEK 4.8m−SEK 866,000−SEK 520,000−SEK 1.3m−SEK 13.9m
Free cash flow−SEK 41.2m−SEK 60.9m−SEK 41.0m−SEK 68.3m−SEK 42.0m−SEK 15.5m−SEK 38.4m−SEK 29.3m−SEK 23.8m−SEK 52.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 7.1mSEK 11.4mSEK 18.3mSEK 15.0mSEK 8.3mSEK 12.3mSEK 17.2mSEK 12.6m
Gross profitSEK 3.2mSEK 6.4mSEK 11.0mSEK 9.2mSEK 4.4mSEK 8.5mSEK 11.5mSEK 8.9m
Operating income−SEK 12.6m−SEK 13.5m−SEK 11.0m−SEK 8.3m−SEK 14.9m−SEK 18.0m−SEK 13.7m−SEK 6.4m
Net income−SEK 13.0m−SEK 13.5m−SEK 11.0m−SEK 8.4m−SEK 14.5m−SEK 18.0m−SEK 13.3m−SEK 7.2m
Diluted earnings per share-0.05-0.06-0.05-0.03-0.06-0.07-0.05-0.03
Cash from operations−SEK 11.0m−SEK 6.0m—−SEK 11.0m−SEK 21.0m−SEK 8.0m−SEK 20.0m−SEK 13.0m
Capital spending———−SEK 11.0m————
Free cash flow———−SEK 22.0m————
Total assetsSEK 124.6mSEK 128.1mSEK 142.0mSEK 149.2mSEK 154.7mSEK 181.0mSEK 195.2mSEK 211.9m
Cash and short-term investmentsSEK 13.1mSEK 26.1mSEK 33.1mSEK 33.1mSEK 45.3mSEK 66.6mSEK 75.2mSEK 96.9m
DebtSEK 2.7mSEK 661,000SEK 1.0mSEK 1.3mSEK 1.6mSEK 1.9mSEK 2.2mSEK 2.5m
Shareholders' equitySEK 98.2mSEK 110.9mSEK 124.2mSEK 135.7mSEK 143.7mSEK 158.0mSEK 176.4mSEK 189.5m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue3.3%-13.5%6.8%
Operating income-8.3%33.6%2.6%
Net income-8.9%31.5%2.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin64.2%62.3%63.5%64.9%
Operating margin-104.8%-110.2%-75.2%-78.6%
Net margin-105.6%-112.1%-76.7%-79.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-8.9-7.2-13.0-10.8-28.2-202.0-13.8-3.1-9.0-3.3
Price to sales8.68.412.715.122.424.09.32.54.74.1

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.